GlycoNex, Inc. (4168, hereinafter referred to as GNX), a clinical-stage biotechnology company specializing in glycan-directed ...

Nona Biosciences, a global biotechnology company providing integrated solutions from 'Idea to IND' (I to ITM), today ...

The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...

Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the 13 Biotech Stocks with Huge Upside Potential. Raymond James has started ...

MacroGenics' recent royalty deal extends cash runway, but liquidity concerns remain, and further asset sales or dilution may ...

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...

Why do people develop antibodies to food? While clinicians have long observed that healthy humans develop a particular type ...

A breakthrough treatment has allowed damaged retinal cells to regenerate themselves. The current research has been conducted ...

Scientists have discovered a unique class of small antibodies that are strongly protective against a wide range of SARS ...

Merck & Co., Inc. (NYSE:MRK) is one of the best wide moat stocks to buy now. On June 9, Merck’s preventative antibody shot ...

Hoping to gain an edge in the rapidly growing market are MilliporeSigma and Simtra BioPharma Solutions, which have forged a ...

The FDA has approved Merck’s Enflonasia, a monoclonal antibody designed to prevent respiratory syncytial virus lower respiratory tract disease in newborns and infants. The approval is based on data ...